ArticleCureus2025
The Clinical and Angiographic Profile and Outcomes of Patients With Left Bundle Branch Block (LBBB): An Observational Study From a Tertiary Care Center in North India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Left bundle branch block (LBBB) is a common electrocardiographic abnormality resulting from impaired conduction in both the His-Purkinje system's anterior and posterior left fascicles. LBBB prevalence varies with age, gender, race, and underlying cardiovascular conditions. It affects 0.06-0.1% of the general population, rising to 6-7% in those over 80, and is often detected incidentally in older males. Although once considered a ST-segment-elevation myocardial infarction (STEMI) equivalent in chest pain, recent data indicate a low risk of myocardial infarction. Diagnosing coronary artery disease (CAD) in these patients is challenging due to limitations of noninvasive tests, often necessitating coronary angiography (CAG) for confirmation. CT angiography is typically the first-line test for patients under 65, while stress nuclear imaging or dobutamine stress echo is preferred in those 65 and older. Certain ECG changes, like ST elevation or depression, may suggest myocardial infarction in LBBB cases. This study aimed to examine various demographic and clinical features, as well as outcomes, in patients presenting with symptomatic LBBB Methods This non-randomized, prospective, single-center observational study aimed to evaluate the clinical characteristics, demographic profile, and outcomes of patients presenting with symptomatic LBBB. All enrolled patients underwent CAG, with or without subsequent revascularization, as part of their diagnostic workup. Results A total of 200 symptomatic LBBB patients, comprising 104 males (52%), with a mean age of 60.2 ± 11.4 years, were included in the study. Hypertension and diabetes mellitus were the most common comorbidities, observed in 98 (49%) and 68 (34%) patients, respectively. Additionally, 160 (80%) patients exhibited some degree of left ventricular (LV) systolic dysfunction. CAG showed normal findings in 100 patients (50%), obstructive CAD in 78 (39%), and non-obstructive CAD in 22 (11%). The left anterior descending (LAD) artery was the most involved vessel, affected in 70 patients (70%). Among the 78 patients with obstructive CAD, 72 (92.3%) had severe obstruction. The LAD artery was the most affected vessel, observed in 60 patients (76.9%). Percutaneous coronary intervention (PCI) was performed in 42 patients, eight were referred for coronary artery bypass grafting (CABG), and 28 were managed with guideline-directed medical therapy (GDMT). Age ≥50 years (p=0.005), angina (p<0.001), diabetes mellitus (p<0.001), and LV ejection fraction (LVEF) ≤50% (p=0.006) were significantly associated with obstructive CAD. Mortality was also significantly higher in this group (p=0.001). During the six-month follow-up, 12 patients (6%), all over 70 years, died, resulting in an overall survival rate of 94% despite the high-risk profile. Conclusions Older patients with LBBB who present with angina, cardiovascular risk factors, and LV systolic dysfunction should be evaluated for CAD by using CAG, especially when troponin markers are elevated (troponin I >0.04 ng/mL).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.